Provided by Tiger Trade Technology Pte. Ltd.

Fortrea Holdings Inc.

17.20
+0.18001.06%
Post-market: 17.200.00000.00%18:10 EDT
Volume:1.43M
Turnover:24.63M
Market Cap:1.64B
PE:-18.79
High:17.57
Open:17.10
Low:16.84
Close:17.02
52wk High:21.39
52wk Low:8.31
Shares:95.10M
Float Shares:94.23M
Volume Ratio:1.42
T/O Rate:1.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9151
EPS(LYR):-10.8136
ROE:-15.30%
ROA:0.58%
PB:3.12
PE(LYR):-1.59

Loading ...

Fortrea Grants CFO Jason Knoblauch 106,755 PSUs and 144,434 RSUs as Inducement Awards

Reuters
·
Yesterday

Fortrea Announces Grant of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Immunome (IMNM)

TIPRANKS
·
Sep 10

Fortrea CEO, CFO to Join Baird Global Healthcare Conference Fireside Chat

Reuters
·
Sep 10

Fortrea Reinstates Knoblauch as CFO After Legal Dispute with Former Employer

Dow Jones
·
Sep 10

Fortrea - Reinstates Jason Knoblauch as CFO on September 9, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 10

Fortrea - David Smith Steps Down as Interim CFO, Remains Board Member - SEC Filing

THOMSON REUTERS
·
Sep 10

Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)

TIPRANKS
·
Sep 03

U.S. Stocks on the MOVE-FuelCell, Gold Miners, NetApp

Reuters
·
Sep 03

Fortrea to Buy Worldwide Clinical Trials Early-Phase Services Unit for $45M All-Cash

Reuters
·
Sep 02

Fortrea - Early Phase Services to Join Fortrea's Clinical Pharmacology Services Business Unit

THOMSON REUTERS
·
Sep 02

Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials

THOMSON REUTERS
·
Sep 02

Fortrea - to Buy Early Phase Services Business in All-Cash Deal Valued at $45 Mln

THOMSON REUTERS
·
Sep 02

Fortrea Interim CAO Carrie Elizabeth Russell Files Initial Beneficial Ownership Statement

Reuters
·
Aug 18

Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV ADR (AGMB) and Sana Biotechnology (SANA)

TIPRANKS
·
Aug 17

This Healthcare Stock Could Jump Nearly 40%

Dow Jones
·
Aug 15

Fortrea Director Machelle Sanders Disposes of 9,700 Common Shares Worth $174,697

Reuters
·
Aug 06

Analysts Are Bullish on These Healthcare Stocks: Stoke Therapeutics (STOK), Fortrea Holdings Inc. (FTRE)

TIPRANKS
·
Aug 04

Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC), Alnylam Pharma (ALNY) and Fortrea Holdings Inc. (FTRE)

TIPRANKS
·
Jul 31

Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Fortrea Holdings Inc. (FTRE) and uniQure (QURE)

TIPRANKS
·
Jul 30